This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Oct. 23, 2012


Fungal Meningitis Outbreak
Food and Drug Administration    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Food and Drug Administration is making available two lists of customers (consignees) who received products that were shipped on or after May 21 from New England Compounding Center's Framingham, Mass., facility. The first list includes customer names and addresses, organized by state. The second list contains the same basic information as the first list, but is organized alphabetically by customer name and also includes the specific products shipped, the quantities of product shipped, and the shipping date. The lists were prepared based on information provided by NECC, and FDA cannot vouch for the completeness or accuracy of the lists. Products shipped by NECC may be missing from the list and facility information may be incomplete. Nevertheless, this is the best information we have available, at this time, to help inform facilities and healthcare providers of NECC products shipped to their facilities since May 21. More

 Area and Association News

National Pharmacy Technician Day
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Oct. 23 is National Pharmacy Technician Day. National Pharmacy Technician Day highlights the important role pharmacy technicians play in supporting pharmacists in the delivery of safe and effective patient care.

Pharmacy-Based Immunization Services Certificate Training Program
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Date: Monday, Nov. 12
Early Registration deadline is October 29.
Only 8 spots left. Click to register.


A safe and convenient compliance package to help your patients take their daily medications, wherever they may be.

MediCase requires no expansive heat sealing equipment and it is easily and quickly assembled in your pharmacy to the patient's specific needs.

For more information on Medicase or our other medication compliance products, visit or contact
Diane LaTourelle:

Congratulations to AzPA member Ken Fletcher
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Congratulations to AzPA member Ken Fletcher, Pharm.D., Thatcher, Ariz., with Safeway, on being selected as a finalist in the 2012 Next Generation Awards presented by Pharmacy Times and Parata. Fletcher was nominated in the Civic Leader of the Year category for his service as the AzPA Southeast District Director and his efforts to educate health care providers in his district on the importance of reporting through the Arizona State Board of Pharmacy Controlled Substances Prescription Drug Monitoring Program.

Holiday shopping is upon us
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Remember to purchase your gift cards through AzPA and support pharmacy education in Arizona. Learn more.

The #1 Selling Brain Health Supplement in Drug Stores Nationally.
Healthier Brain • Sharper Mind • Protect Memories
As we age we lose calcium-binding proteins that protect our brain cells. This protein loss affects our ability to learn, retain memories, think and concentrate.* Prevagen® (apoaequorin) replaces these proteins in the body and helps protect our cells during this natural process of aging.* Over the counter, visit:

Shop and support AzPA
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The next time you shop on, visit the AzPA website first and click on the portal on the home page. When you enter through the AzPA website, a portion of your total purchases will come back to AzPA. Bookmark this link.

Not an AzPA member? Join today
AzPA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings. With over 1,500 members, we are a leading association of pharmacists spreading the news and events of our industry. More

 Pharmacy Updates

Meningitis toll rises; pharmacy owners sued
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Executives at the Boston-area pharmacy whose steroid shots have been linked to a deadly meningitis outbreak have been sued in a bid to freeze their personal assets, while the death toll and reported infections continue to rise. Peter McGrath, a lawyer who is a former federal prosecutor, said he was spearheading a civil case that blames Massachusetts-based New England Compounding Center and company officers Barry and Lisa Cadden and Greg Conigliaro for the tainted drugs. The lawsuit was filed on behalf of an unnamed plaintiff in Middlesex County Superior Court in suburban Boston, court records show. More

Pharmacist telemonitoring improves blood pressure management
Pharmacy Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Telemonitoring by pharmacist case managers appears to be a viable method of improving blood pressure control in patients with hypertension, according to the results of a study published in the recent edition of the Journal of Clinical Hypertension. In particular, researchers noted that patients in the telemonitoring group that checked in with pharmacist case managers were particularly compliant with self-monitoring procedures. More

FDA raises awareness of fake pharmacies with 'BeSafeRX'
The Legal Examiner    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Have you bought a medical prescription drug online recently? If so, you were at a high risk of being scammed. According to the National Association of Boards of Pharmacy, less than three percent of online pharmacies meet state and federal laws. That means 97 percent are either breaking the law or operating outside the codes of proper practice. Fortunately, the FDA has launched a new national campaign to raise awareness of the issue, and help consumers to determine which sites are legitimate. More

FDA nod for Bristol-Myers Squibb drug label update
NASDAQ    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Bristol-Myers Squibb Company recently announced that the Food and Drug Administration has cleared a label update for its hepatitis B virus therapy, Baraclude. The FDA has allowed Bristol-Myers to update Baraclude's label so that data on African-Americans and liver transplant recipients suffering from HBV may be included. More

 In the News

Anti-psychotic drug prescription should lessen for people with dementia
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The challenge of reducing the usage of anti-psychotic drugs among dementia patients proves to be more difficult than originally estimated. This has become a vital public health issue in the U.K., because these drugs are associated with up to 1,800 deaths a year in people with dementia. The actual usage of anti-psychotic drugs in dementia patients may be up to 46 percent more than any original numbers suggests. More

Pharmacies say Methcheck system is working
WLNS-TV    Share    Share on FacebookTwitterShare on LinkedinE-mail article
After another case of meth abuse in Jackson County, Mich., officials from the Tri-county Metro Narcotics Squad say meth labs are popping up because it's now easier to make. Pharmacies however say it's not because the supplies are easier to purchase. Thanks to the federal Combat Methamphetamine Epidemic Act, buying and abusing products like Sudafed and other cold medicines have become more difficult over the last few years. More

Harness the Rejuvenation Power of Your Own Stem Cells
Important benefits of Stem Cell 100™
  • Powerful anti-aging properties
  • Provides immune support
  • Promotes younger looking skin
  • Supports cardiovascular health
  • Renews health and vitality
  • JRS Pharma
    Powdered cellulose is used as an economic and inert diluent in tableting and capsule filling. Especially in wet granulation it works synergistically with other economic excipients such as starch or lactose. Combined with these, ARBOCEL® improves tablet hardness and disintegration time.

    Noveon AA-1 Polycarbophil, USP is a high molecular weight acrylic acid polymer crosslinked with divinyl glycol. It provides excellent bioadhesive properties and has been used extensively to enhance the delivery of active ingredients to various mucous membranes.

     FDA News

    Jetrea approved to treat eye condition
    HealthDay    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Jetrea has been approved by the Food and Drug Administration to treat an eye condition called symptomatic vitreomacular adhesion. Jetrea helps break down proteins that are responsible for VMA, preventing the need for surgery to control the condition, the agency said. More

    FDA panel recommends GI drug
    MedPage Today (free subscription)    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    An FDA panel voted unanimously to recommend approval of a drug to help patients who have lost the ability to absorb nutrients, despite the agency's concerns over the manufacturer's risk-management plan. The 12-0 vote to recommend approval of teduglutide to treat short bowel syndrome came even though FDA reviewers raised doubts about the strength of the proposed plan to monitor the drug's safety and use after approval. Members of the FDA's Gastrointestinal Drugs Advisory Committee appeared not to share those same concerns. More

    FDA review raises safety concerns about mipomersen
    Forbes    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    An FDA review raises a number of potentially significant safety concerns about the cholesterol-lowering drug mipomersen. The review appeared ahead of a recent meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to evaluate Genzyme's new drug application for use of the drug as an adjunct to maximally tolerated lipid-lowering medications and diet to reduce LDL, apolipoprotein B, total cholesterol, non-high density lipoprotein-cholesterol and lipoprotein(a) in patients with homozygous familial hypercholesterolemia. Mipomersen is an antisense oligonucleotide inhibitor which targets apoB-100. More

    Abraxane approved to treat advanced lung cancer
    HealthDay    Share    Share on FacebookTwitterShare on LinkedinE-mail article
    Abraxane has been approved by the Food and Drug Administration — in combination with the drug carboplatin — to treat advanced or spreading non-small cell lung cancer among people who aren't candidates for surgery or radiation therapy, the agency recently said. Abraxane was first approved in 2005 to treat breast cancer. More

    AzPA Pharmacy Flash
    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Danielle Wegert, Content Editor, 469.420.2696   
    Contribute news

    This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
    Recent issues
    Oct. 23, 2012
    Oct. 16, 2012
    Oct. 9, 2012
    Oct. 2, 2012

    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063